PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

PacBio and TychoBio are collaborating to train AI models specifically aimed at advancing RNA therapeutics for rare diseases, combining long-read sequencing technology with AI-driven drug discovery.

This Wire brief sits within Fusion42's coverage of Biotech, AI Frontier Models and Drug Discovery.